These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 15170996)

  • 1. [Chemoradiation using 5-fluorouracil (5-FU) and nedaplatin (NDP) for gynecological malignancy--the relation between hemotoxicity and sequence of 5-FU and NDP].
    Itoh Y; Ishihara S; Kumada S; Takai K; Iwata M; Nakamura T; Kawase S; Suzuki K; Mori Y; Hirasawa N; Satoh C; Fukushima H; Okuda T; Ota T; Yanagawa S; Ishigaki T
    Gan To Kagaku Ryoho; 2004 May; 31(5):797-9. PubMed ID: 15170996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nedaplatin (NDP)-combination therapy (NDP/5-FU,NDP/S-1) for oral cancer].
    Maruoka Y; Ando T; Ogiuchi Y; Ogiuchi H
    Gan To Kagaku Ryoho; 2007 May; 34(5):713-7. PubMed ID: 17496443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-institute phase I/II trial of alternating chemoradiotherapy with 5-FU and nedaplatin for esophageal carcinoma.
    Kodaira T; Fuwa N; Kamata M; Furutani K; Tachibana H; Yamazaki T
    Anticancer Res; 2006; 26(1B):471-8. PubMed ID: 16739307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective case series of 15 patients treated with chemoradiation using 5-FU and nedaplatin for gynecological malignancy: with regard to hemotoxicity.
    Itoh Y; Ikeda M; Hirasawa N; Okuda T; Murao T; Kubota S; Okada T; Naganawa S; Ishigaki T
    Nagoya J Med Sci; 2014 Feb; 76(1-2):11-6. PubMed ID: 25129987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with esophageal cancer.
    Sato Y; Takayama T; Sagawa T; Okamoto T; Miyanishi K; Sato T; Araki H; Iyama S; Abe S; Murase K; Takimoto R; Nagakura H; Hareyama M; Kato J; Niitsu Y
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):570-6. PubMed ID: 16463059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced antitumor efficacy of nedaplatin with 5-fluorouracil against human squamous carcinoma xenografts.
    Takeda Y; Kasai H; Uchida N; Yoshida H; Maekawa R; Sugita K; Yoshioka T
    Anticancer Res; 1999; 19(5B):4059-64. PubMed ID: 10628354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination chemotherapy with nedaplatin (CDGP) and 5-FU for oral cancer].
    Maruoka Y; Ando T; Hoshino M; Ogiuchi Y; Nishihara N; Okamoto T; Fukada K; Kuwazawa T; Ogiuchi H
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):421-5. PubMed ID: 11915732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Augmented antitumor efficacy of combination chemotherapy of nedaplatin with 5-fluorouracil in in vivo murine and human tumor model].
    Uchida N; Takeda Y; Kasai H; Hojo K; Wada T; Nishida K; Maekawa R; Sugita K; Yoshioka T
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2267-74. PubMed ID: 9881084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
    ; Ryan DP; Niedzwiecki D; Hollis D; Mediema BE; Wadler S; Tepper JE; Goldberg RM; Mayer RJ
    J Clin Oncol; 2006 Jun; 24(16):2557-62. PubMed ID: 16636336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of esophageal carcinoma with multiple liver metastases successfully treated with nedaplatin (NDP) and 5-fluorouracil (5-FU) combined with radiotherapy].
    Kaneko K; Ito H; Ito T; Konishi K; Kurahashi T; Yamamoto T; Eguchi J; Kitahara T; Mitamura K
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):831-4. PubMed ID: 11432353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: a randomized study of two different schedules of oxaliplatin.
    Petrioli R; Pascucci A; Francini E; Marsili S; Sciandivasci A; Tassi R; Civitelli S; Tanzini G; Lorenzi M; Francini G
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):105-11. PubMed ID: 17429632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination chemotherapy with nedaplatin and 5-fluorouracil for oral squamous cell carcinomas].
    Yamaoka K; Fukuda M; Kuwajima S; Hagiwara H; Toshima S; Matsuoka A; Ohnuki T; Seki H; Nagai H; Iino M; Sageshima M
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):951-5. PubMed ID: 12894709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of combination chemotherapy with 5-fluorouracil (5-FU) and nedaplatin (NDP): adverse effects and eecommended dose of NDP administered after 5-FU.
    Fuwa N; Kodaira T; Kamata M; Matsumoto A; Furutani K; Tachibana H; Ito Y
    Am J Clin Oncol; 2002 Dec; 25(6):565-9. PubMed ID: 12477999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phase II clinical trial of home-produced Nedaplatin in treating advanced esophageal carcinoma].
    Xu RH; Shi YX; Guan ZZ; Jiang WQ; Huang H; Ma ZY; Wang JH; Hu XH; Xie WM; Li XG; Liu YL; Pan LX; Dai AD; Zhuang W; Zhang C
    Ai Zheng; 2006 Dec; 25(12):1565-8. PubMed ID: 17166388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phase I study of the combination of nedaplatin (NED), adriamycin (ADM), and 5-fluorouracil (5-FU) (NAF) for treatment of unresectable advanced esophageal cancer].
    Hirao M; Fujitani K; Tsujinaka T
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):53-6. PubMed ID: 15675582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.
    Kemeny N; Garay CA; Gurtler J; Hochster H; Kennedy P; Benson A; Brandt DS; Polikoff J; Wertheim M; Shumaker G; Hallman D; Burger B; Gupta S
    J Clin Oncol; 2004 Dec; 22(23):4753-61. PubMed ID: 15570076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
    Yamada Y; Ohtsu A; Boku N; Miyata Y; Shimada Y; Doi T; Muro K; Muto M; Hamaguchi T; Mera K; Yano T; Tanigawara Y; Shirao K
    Jpn J Clin Oncol; 2006 Apr; 36(4):218-23. PubMed ID: 16684860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose escalation study of nedaplatin with 5-fluorouracil in combination with alternating radiotherapy in patients with head and neck cancer.
    Fuwa N; Kodaira T; Tachibana H; Nakamura T; Daimon T
    Jpn J Clin Oncol; 2007 Mar; 37(3):161-7. PubMed ID: 17332057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation therapy combined with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for Japanese stage II-IV esophageal cancer compared with cisplatin plus 5-fluorouracil regimen: a retrospective study.
    Yamashita H; Nakagawa K; Tago M; Igaki H; Nakamura N; Shiraishi K; Sasano N; Ohtomo K
    Dis Esophagus; 2006; 19(1):15-9. PubMed ID: 16364038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I evaluation of continuous 5-fluorouracil infusion followed by weekly paclitaxel in patients with advanced or recurrent gastric cancer.
    Kondo K; Kobayashi M; Kojima H; Hirabayashi N; Kataoka M; Araki K; Matsui T; Takiyama W; Miyashita Y; Nakazato H; Nakao A; Sakamoto J
    Jpn J Clin Oncol; 2005 Jun; 35(6):332-7. PubMed ID: 15961435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.